ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

GOS Ameliorates Nonalcoholic Fatty Liver Disease Induced by High Fat and High Sugar Diet through Lipid Metabolism and Intestinal Microbes

Qiu, Shuting; Chen, Jiajia; Bai, Yan; He, Jincan; Cao, Hua; Che, Qishi; Guo, Jiao*; Su, Zhengquan*广东药学院
OncoImmunology2022-7DOI: 10.3390/nu14132749
10被引6阅读
引用收藏
分享

摘要

The treatment of nonalcoholic fatty liver disease (NAFLD) remains very challenging. This study investigated the therapeutic effect of galactose oligosaccharide (GOS), an important prebiotic, on NAFLD through in vivo and in vitro experiments and preliminarily explored the mechanism by which GOS improves liver lipid metabolism and inflammation through liver and intestinal microbiological analysis. The results of mouse liver lipidomics showed that GOS could promote body thermogenesis in mice with high-fat and high-sugar diet (HFHSD)-induced NAFLD, regulate lipolysis in liver fat cells, and accelerate glycine and cholesterol metabolism. GOS dose-dependently reduced the contents of total cholesterol (TC) and triglyceride (TG) in cells and reduced the accumulation of lipid droplets in cells. GOS also reduced the Firmicutes/Bacteroidetes ratio and altered the composition of the intestinal microbiota in mice fed a HFHSD. GOS can improve liver lipid metabolism and intestinal structure of NAFLD. These results provide a theoretical and experimental basis supporting the use of GOS as a health food with anti-NAFLD functions.

学科与关键词

关键词
galactose oligosaccharidenonalcoholic fatty liver diseaselipid metabolisminflammationintestinal microbesprebiotics
相关
加载中…
  • Anti-obesity effects of galacto-oligosaccharides in obese rats
    Kong, Shang; Huang, Xingjun; Cao, Hua; Bai, Yan; Che, Qishi; Nie, Hong*; Su, Zhengquan*European Journal of Pharmacology, 2022, 917: 174728.被引 5
  • Glucosamine Improves Non-Alcoholic Fatty Liver Disease Induced by High-Fat and High-Sugar Diet through Regulating Intestinal Barrier Function, Liver Inflammation, and Lipid Metabolism
    Li, Feng; Zhang, Zhengyan; Bai, Yan; Che, Qishi; Cao, Hua; Guo, Jiao*; Su, Zhengquan*MOLECULES, 2023, 28(19): 6918.被引 1
  • Marine Chitooligosaccharide Alters Intestinal Flora Structure and Regulates Hepatic Inflammatory Response to Influence Nonalcoholic Fatty Liver Disease
    Feng, Jiayao; Liu, Yongjian; Chen, Jiajia; Bai, Yan; He, Jincan; Cao, Hua; Che, Qishi; Guo, Jiao*; Su, Zhengquan*Marine Drugs, 2022, 20(6): 383.被引 11
查看全部 →

发表信息

论文状态
公开发表
期刊
OncoImmunology
发表日期
2022-07
卷期
第 14 卷, 第 13 期
页码
2749
DOI
10.3390/nu14132749
语言
ENGLISH
期刊收录
SCIE
期刊等级
2区
成果收录
SCIE
资助标注
Science and Technology Program of Guangzhou, China [202103000089]; Guangdong Demonstration Base for Joint Cultivation of Postgraduates; Science Foundation for Distinguished Young Scholars of Guangdong [2020B1515020026]; National Natural Science Foundation of China [21804025]

作者

  • Q

    Qiu, Shuting (第一作者)

    guangdong pharmaceut univ · new

  • C

    Chen, Jiajia

    guangdong pharmaceut univ · new

查看全部 8 位作者收起作者
  • B

    Bai, Yan

    guangdong pharmaceut univ

  • H

    He, Jincan

    guangdong pharmaceut univ

  • C

    Cao, Hua

    guangdong pharmaceut univ

  • C

    Che, Qishi

  • G

    Guo, Jiao (通讯)

    guangdong pharmaceut univ

  • S

    Su, Zhengquan (通讯)

    guangdong pharmaceut univ · new

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417